Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 43 studies | 48% ± 22% | |
endothelial cell of lymphatic vessel | 28 studies | 66% ± 27% | |
mast cell | 18 studies | 33% ± 11% | |
capillary endothelial cell | 16 studies | 57% ± 26% | |
endothelial cell of artery | 13 studies | 41% ± 20% | |
vein endothelial cell | 12 studies | 49% ± 24% | |
platelet | 10 studies | 81% ± 11% | |
endothelial cell of vascular tree | 10 studies | 48% ± 23% | |
type I pneumocyte | 8 studies | 49% ± 18% | |
fibroblast | 6 studies | 25% ± 9% | |
megakaryocyte | 6 studies | 82% ± 18% | |
pericyte | 5 studies | 40% ± 18% | |
smooth muscle cell | 5 studies | 23% ± 4% | |
basal cell | 5 studies | 34% ± 12% | |
glomerular endothelial cell | 4 studies | 77% ± 8% | |
mesothelial cell | 4 studies | 37% ± 10% | |
type II pneumocyte | 3 studies | 24% ± 9% | |
erythrocyte | 3 studies | 17% ± 1% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 34% ± 9% | |
hematopoietic stem cell | 3 studies | 45% ± 36% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 26% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 6569.09 | 649 / 653 | 89% | 70.01 | 536 / 605 |
prostate | 87% | 2507.11 | 214 / 245 | 94% | 30.68 | 470 / 502 |
lung | 100% | 11018.01 | 577 / 578 | 81% | 31.95 | 932 / 1155 |
kidney | 83% | 1961.80 | 74 / 89 | 93% | 70.78 | 841 / 901 |
adrenal gland | 79% | 1491.64 | 204 / 258 | 86% | 33.20 | 197 / 230 |
esophagus | 92% | 4614.45 | 1331 / 1445 | 54% | 13.11 | 99 / 183 |
breast | 100% | 8771.02 | 459 / 459 | 37% | 8.47 | 410 / 1118 |
brain | 49% | 855.26 | 1293 / 2642 | 87% | 30.92 | 615 / 705 |
bladder | 100% | 5877.00 | 21 / 21 | 35% | 10.60 | 177 / 504 |
uterus | 99% | 4941.55 | 169 / 170 | 35% | 8.68 | 162 / 459 |
intestine | 92% | 6632.41 | 885 / 966 | 34% | 7.60 | 178 / 527 |
ovary | 97% | 3426.59 | 175 / 180 | 16% | 2.96 | 69 / 430 |
stomach | 64% | 1601.88 | 228 / 359 | 46% | 10.11 | 132 / 286 |
adipose | 100% | 9570.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 6552.10 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 99% | 5028.20 | 856 / 861 | 0% | 0 | 0 / 0 |
liver | 15% | 225.79 | 35 / 226 | 64% | 15.15 | 261 / 406 |
muscle | 79% | 1513.28 | 636 / 803 | 0% | 0 | 0 / 0 |
pancreas | 7% | 89.56 | 23 / 328 | 72% | 16.29 | 128 / 178 |
skin | 48% | 896.22 | 868 / 1809 | 20% | 3.49 | 96 / 472 |
blood vessel | 67% | 1669.24 | 889 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 36% | 16.79 | 16 / 45 |
peripheral blood | 20% | 314.57 | 190 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 10% | 1.23 | 3 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097320 | Biological process | plasma membrane tubulation |
GO_0045121 | Cellular component | membrane raft |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005901 | Cellular component | caveola |
GO_0005737 | Cellular component | cytoplasm |
GO_0005080 | Molecular function | protein kinase C binding |
GO_0001786 | Molecular function | phosphatidylserine binding |
GO_0005515 | Molecular function | protein binding |
GO_0005543 | Molecular function | phospholipid binding |
Gene name | CAVIN2 |
Protein name | Caveolae-associated protein 2 (Cavin-2) (PS-p68) (Phosphatidylserine-binding protein) (Serum deprivation-response protein) |
Synonyms | SDPR |
Description | FUNCTION: Plays an important role in caveolar biogenesis and morphology. Regulates caveolae morphology by inducing membrane curvature within caveolae . Plays a role in caveola formation in a tissue-specific manner. Required for the formation of caveolae in the lung and fat endothelia but not in the heart endothelia. Negatively regulates the size or stability of CAVIN complexes in the lung endothelial cells. May play a role in targeting PRKCA to caveolae (By similarity). . |
Accessions | O95810 ENST00000304141.5 |